Further research revealed that positive expression of Hec1 protein is associated with adverse clinical features in cervical cancer patients, such as increased FIGO staging, enhanced lymph node metastasis, deeper tumor stromal infiltration, larger tumor diameter, and reduced survival rates. This evidence concerns the gene NDC80 and neoplasm.